PET-CT scan for thyroid and parathyroid evaluation
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at how well PET-CT scans can find thyroid or parathyroid problems. The trial uses scans that are already part of your regular care to learn more about these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- You have a thyroid or parathyroid condition, or a PET-CT scan that shows unusual activity
- You had a needle aspiration (a small sample taken) within the last 12 months (for the retrospective part) or are scheduled for one within 12 months (for the prospective part)
- You must give permission to use your medical information
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent (68Ga-DOTA-CCK-FS) that helps doctors see medullary thyroid carcinoma (MTC) and other tumors with CCK-2 receptors using a PET/CT scan. It may help find or monitor these tumors more clearly.
This study uses past and future parathyroid scan data to train and test an AI tool. The goal is to improve how the scans are interpreted using nuclear medicine imaging from a specific scanning process.
This trial tests a special PET scan to better locate overactive parathyroid glands before surgery. It may help guide treatment for people with primary hyperparathyroidism.
This study uses a special PET scan (18F-FDG PET/CT) to get a clearer picture of thyroid nodules with uncertain biopsy results. The goal is to help doctors decide whether surgery is needed.
This study checks how well a new PET/CT scan (18F-TFB) can find thyroid cancer after a standard iodine whole-body scan. It may help doctors see where the cancer is using an added imaging test, which could improve planning for care.
This trial tests a new type of PET scan (F-18 Tetrafluoroborate) to find thyroid cancer cells that don't show up on standard scans. It's for people who have had surgery and radioactive iodine therapy but still have signs of cancer in their blood tests.
Hear when a new Medullary Thyroid Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.